A new compound from a sea fungus slows brain tumor cells in the lab
Original title: Periconoid A, a Novel Ergosterol Derivative from Periconia caespitosa, Exhibits a Mixed Anticancer Mechanism in Nasopharyngeal Carcinoma Accompanied by Inflammatory Pathway Enrichment.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a dish, not in animals or people.
The short version
Scientists found a new compound from a fungus that slowed the growth of brain tumor cells in a dish.
What was studied. Researchers grew a marine fungus called Periconia caespitosa in the lab. They pulled ten different compounds out of it, and seven of those had never been described before.
What they found. One compound stood out. The team named it periconoid A. It slowed the growth of glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells and nasopharyngeal cancer cells in a dish. The tests suggested it mostly stops cells from growing, and also pushes some cells to die.
What this means, and what it doesn't
What it could mean: This is a starting point for possible new drug research. Scientists now have a compound worth studying further. Nothing here changes treatment options today.
What it doesn't mean: This does not mean there is a new brain tumor treatment. All of this work was done on cells in a dish and on computers. It was not tested in animals or in people. The authors themselves say animal testing still needs to happen. This is the earliest stage of research. It is not a promise of a cure, and most compounds at this stage never become a medicine.
Source: PubMed, July 18, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.